Report for Harangi M

General

Full name : Harangi Mariann

First name : Marian

Mail : First Department of Medicine, University of Debrecen, Medical and Health Science Center, Debrecen

Zip Code :

City :

Country : Hungary

Email : mharangi@hotmail.com

Phone :

Fax :

Website : \/\/www.doktori.hu\/index.php?menuid=192&lang=EN&sz_ID=7724

Directory :

References (29)

Title : Assessment of amino-terminal C-type natriuretic peptide serum level and its correlation with high-density lipoprotein structure and function in patients with end stage renal disease before and after kidney transplantation - Szentimrei_2023_Chem.Biol.Interact_14ChEPon_385_110749
Author(s) : Szentimrei R , Lorincz H , Szentpeteri A , Varga VE , Seres I , Varga , Nemes B , Harangi M , Paragh G
Ref : Chemico-Biological Interactions , 385 :110749 , 2023
Abstract : Szentimrei_2023_Chem.Biol.Interact_14ChEPon_385_110749
ESTHER : Szentimrei_2023_Chem.Biol.Interact_14ChEPon_385_110749
PubMedSearch : Szentimrei_2023_Chem.Biol.Interact_14ChEPon_385_110749
PubMedID: 37802408

Title : High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus - Gaal_2016_Lipids.Health.Dis_15_60
Author(s) : Gaal K , Tarr T , Lorincz H , Borbas V , Seres I , Harangi M , Fulop P , Paragh G
Ref : Lipids Health Dis , 15 :60 , 2016
Abstract : Gaal_2016_Lipids.Health.Dis_15_60
ESTHER : Gaal_2016_Lipids.Health.Dis_15_60
PubMedSearch : Gaal_2016_Lipids.Health.Dis_15_60
PubMedID: 27004558

Title : Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications - Zsiros_2016_Clin.Biochem_49_862
Author(s) : Zsiros N , Koncsos P , Lorincz H , Seres I , Katko M , Szentpeteri A , Varga VE , Fulop P , Paragh G , Harangi M
Ref : Clinical Biochemistry , 49 :862 , 2016
Abstract : Zsiros_2016_Clin.Biochem_49_862
ESTHER : Zsiros_2016_Clin.Biochem_49_862
PubMedSearch : Zsiros_2016_Clin.Biochem_49_862
PubMedID: 27129797

Title : Paraoxonase-1 and adipokines: potential links between obesity and atherosclerosis - Fulop_2016_Chem.Biol.Interact_259_388
Author(s) : Fulop P , Harangi M , Seres I , Paragh G
Ref : Chemico-Biological Interactions , 259 :388 , 2016
Abstract : Fulop_2016_Chem.Biol.Interact_259_388
ESTHER : Fulop_2016_Chem.Biol.Interact_259_388
PubMedSearch : Fulop_2016_Chem.Biol.Interact_259_388
PubMedID: 27062889

Title : Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients - Locsey_2013_Transplant.Proc_45_3685
Author(s) : Locsey L , Seres I , Sztanek F , Harangi M , Padra J , Kovacs D , Fedor R , Asztalos L , Paragh G
Ref : Transplant Proc , 45 :3685 , 2013
Abstract : Locsey_2013_Transplant.Proc_45_3685
ESTHER : Locsey_2013_Transplant.Proc_45_3685
PubMedSearch : Locsey_2013_Transplant.Proc_45_3685
PubMedID: 24314997

Title : Low high-density lipoprotein cholesterol is not responsible for decreased paraoxonase activity in chronic renal failure - Varga_2012_Kidney.Blood.Press.Res_35_265
Author(s) : Varga E , Seres I , Harangi M , Karpati I , Koncsos P , Sztanek F , Paragh G
Ref : Kidney Blood Press Res , 35 :265 , 2012
Abstract : Varga_2012_Kidney.Blood.Press.Res_35_265
ESTHER : Varga_2012_Kidney.Blood.Press.Res_35_265
PubMedSearch : Varga_2012_Kidney.Blood.Press.Res_35_265
PubMedID: 22378349

Title : Effect of nutritional status on human paraoxonase-1 activity in patients with chronic kidney disease - Sztanek_2012_Kidney.Blood.Press.Res_36_310
Author(s) : Sztanek F , Seres I , Harangi M , Locsey L , Koncsos P , Paragh G
Ref : Kidney Blood Press Res , 36 :310 , 2012
Abstract : Sztanek_2012_Kidney.Blood.Press.Res_36_310
ESTHER : Sztanek_2012_Kidney.Blood.Press.Res_36_310
PubMedSearch : Sztanek_2012_Kidney.Blood.Press.Res_36_310
PubMedID: 23235285

Title : Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease - Sztanek_2012_Nephrol.Dial.Transplant_27_2866
Author(s) : Sztanek F , Seres I , Harangi M , Locsey L , Padra J , Paragh GJ , Asztalos L , Paragh G
Ref : Nephrol Dial Transplant , 27 :2866 , 2012
Abstract : Sztanek_2012_Nephrol.Dial.Transplant_27_2866
ESTHER : Sztanek_2012_Nephrol.Dial.Transplant_27_2866
PubMedSearch : Sztanek_2012_Nephrol.Dial.Transplant_27_2866
PubMedID: 22247228

Title : Favorable effect of short-term lifestyle intervention on human paraoxonase-1 activity and adipokine levels in childhood obesity - Koncsos_2011_J.Am.Coll.Nutr_30_333
Author(s) : Koncsos P , Seres I , Harangi M , Pall D , Jozsa L , Bajnok L , Nagy EV , Paragh G
Ref : J Am Coll Nutr , 30 :333 , 2011
Abstract : Koncsos_2011_J.Am.Coll.Nutr_30_333
ESTHER : Koncsos_2011_J.Am.Coll.Nutr_30_333
PubMedSearch : Koncsos_2011_J.Am.Coll.Nutr_30_333
PubMedID: 22081619

Title : Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels - Koncsos_2010_Pediatr.Res_67_309
Author(s) : Koncsos P , Seres I , Harangi M , Illyes I , Jozsa L , Gonczi F , Bajnok L , Paragh G
Ref : Pediatr Res , 67 :309 , 2010
Abstract : Koncsos_2010_Pediatr.Res_67_309
ESTHER : Koncsos_2010_Pediatr.Res_67_309
PubMedSearch : Koncsos_2010_Pediatr.Res_67_309
PubMedID: 19915520

Title : Alteration of PON1 activity in adult and childhood obesity and its relation to adipokine levels - Seres_2010_Adv.Exp.Med.Biol_660_129
Author(s) : Seres I , Bajnok L , Harangi M , Sztanek F , Koncsos P , Paragh G
Ref : Advances in Experimental Medicine & Biology , 660 :129 , 2010
Abstract : Seres_2010_Adv.Exp.Med.Biol_660_129
ESTHER : Seres_2010_Adv.Exp.Med.Biol_660_129
PubMedSearch : Seres_2010_Adv.Exp.Med.Biol_660_129
PubMedID: 20221876

Title : Decreased human paraoxonase-1 activity in patients with Sjogren's syndrome - Szanto_2010_Int.Immunol_22_605
Author(s) : Szanto A , Harangi M , Seres I , Paragh G , Zeher M
Ref : Int Immunol , 22 :605 , 2010
Abstract : Szanto_2010_Int.Immunol_22_605
ESTHER : Szanto_2010_Int.Immunol_22_605
PubMedSearch : Szanto_2010_Int.Immunol_22_605
PubMedID: 20497955

Title : Discordance in human paraoxonase-1 gene between phenotypes and genotypes in chronic kidney disease - Paragh_2009_Nephron.Clin.Pract_113_c46
Author(s) : Paragh G , Seres I , Harangi M , Pocsai Z , Asztalos L , Locsey L , Szeles G , Kardos L , Varga E , Karpati I , Adany R
Ref : Nephron Clin Pract , 113 :c46 , 2009
Abstract : Paragh_2009_Nephron.Clin.Pract_113_c46
ESTHER : Paragh_2009_Nephron.Clin.Pract_113_c46
PubMedSearch : Paragh_2009_Nephron.Clin.Pract_113_c46
PubMedID: 19602899

Title : Serum cystatin C is a determinant of paraoxonase activity in hemodialyzed and renal transplanted patients - Varga_2009_Dis.Markers_26_141
Author(s) : Varga E , Seres I , Harangi M , Sztanek F , Asztalos L , Locsey L , Borbas B , Szegedi J , Karpati I , Paragh G
Ref : Dis Markers , 26 :141 , 2009
Abstract : Varga_2009_Dis.Markers_26_141
ESTHER : Varga_2009_Dis.Markers_26_141
PubMedSearch : Varga_2009_Dis.Markers_26_141
PubMedID: 19597297

Title : Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity - Harangi_2009_Transl.Res_153_190
Author(s) : Harangi M , Mirdamadi HZ , Seres I , Sztanek F , Molnar M , Kassai A , Derdak Z , Illyes L , Paragh G
Ref : Transl Res , 153 :190 , 2009
Abstract : Harangi_2009_Transl.Res_153_190
ESTHER : Harangi_2009_Transl.Res_153_190
PubMedSearch : Harangi_2009_Transl.Res_153_190
PubMedID: 19304278

Title : Benefits and difficulties in measuring HDL subfractions and human paraoxonase-1 activity during statin treatment - Harangi_2009_Cardiovasc.Drugs.Ther_23_501
Author(s) : Harangi M , Seres I , Harangi J , Paragh G
Ref : Cardiovasc Drugs Ther , 23 :501 , 2009
Abstract : Harangi_2009_Cardiovasc.Drugs.Ther_23_501
ESTHER : Harangi_2009_Cardiovasc.Drugs.Ther_23_501
PubMedSearch : Harangi_2009_Cardiovasc.Drugs.Ther_23_501
PubMedID: 19859794

Title : Association between human paraoxonase 1 activity and intima-media thickness in subjects under 55 years of age with carotid artery disease - Harangi_2008_Cerebrovasc.Dis_25_122
Author(s) : Harangi M , Seres I , Magyar MT , Csipo I , Sipka S , Valikovics A , Csiba L , Bereczki D , Paragh G
Ref : Cerebrovasc Dis , 25 :122 , 2008
Abstract : Harangi_2008_Cerebrovasc.Dis_25_122
ESTHER : Harangi_2008_Cerebrovasc.Dis_25_122
PubMedSearch : Harangi_2008_Cerebrovasc.Dis_25_122
PubMedID: 18073465

Title : The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters - Mirdamadi_2008_Br.J.Clin.Pharmacol_66_366
Author(s) : Mirdamadi HZ , Sztanek F , Derdak Z , Seres I , Harangi M , Paragh G
Ref : British Journal of Clinical Pharmacology , 66 :366 , 2008
Abstract : Mirdamadi_2008_Br.J.Clin.Pharmacol_66_366
ESTHER : Mirdamadi_2008_Br.J.Clin.Pharmacol_66_366
PubMedSearch : Mirdamadi_2008_Br.J.Clin.Pharmacol_66_366
PubMedID: 18492126

Title : Orlistat increases serum paraoxonase activity in obese patients - Audikovszky_2007_Nutr.Metab.Cardiovasc.Dis_17_268
Author(s) : Audikovszky M , Pados G , Seres I , Harangi M , Fulop P , Katona E , Illyes L , Winkler G , Katona EM , Paragh G
Ref : Nutr Metab Cardiovasc Dis , 17 :268 , 2007
Abstract : Audikovszky_2007_Nutr.Metab.Cardiovasc.Dis_17_268
ESTHER : Audikovszky_2007_Nutr.Metab.Cardiovasc.Dis_17_268
PubMedSearch : Audikovszky_2007_Nutr.Metab.Cardiovasc.Dis_17_268
PubMedID: 17134960

Title : Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome - Paragh_2006_Br.J.Clin.Pharmacol_61_694
Author(s) : Paragh G , Seres I , Harangi M , Erdei A , Audikovszky M , Debreczeni L , Kovacsay A , Illyes L , Pados G
Ref : British Journal of Clinical Pharmacology , 61 :694 , 2006
Abstract : Paragh_2006_Br.J.Clin.Pharmacol_61_694
ESTHER : Paragh_2006_Br.J.Clin.Pharmacol_61_694
PubMedSearch : Paragh_2006_Br.J.Clin.Pharmacol_61_694
PubMedID: 16722831

Title : Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia - Paragh_2004_Curr.Med.Res.Opin_20_1321
Author(s) : Paragh G , Torocsik D , Seres I , Harangi M , Illyes L , Balogh Z , Kovacs P
Ref : Curr Med Res Opin , 20 :1321 , 2004
Abstract : Paragh_2004_Curr.Med.Res.Opin_20_1321
ESTHER : Paragh_2004_Curr.Med.Res.Opin_20_1321
PubMedSearch : Paragh_2004_Curr.Med.Res.Opin_20_1321
PubMedID: 15324535

Title : Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage - Harangi_2004_Eur.J.Clin.Pharmacol_60_685
Author(s) : Harangi M , Seres I , Varga Z , Emri G , Szilvassy Z , Paragh G , Remenyik E
Ref : European Journal of Clinical Pharmacology , 60 :685 , 2004
Abstract : Harangi_2004_Eur.J.Clin.Pharmacol_60_685
ESTHER : Harangi_2004_Eur.J.Clin.Pharmacol_60_685
PubMedSearch : Harangi_2004_Eur.J.Clin.Pharmacol_60_685
PubMedID: 15490140

Title : The effect of micronised fenofibrate on paraoxonase activity in patients with coronary heart disease - Paragh_2003_Diabetes.Metab_29_613
Author(s) : Paragh G , Seres I , Harangi M , Balogh Z , Illyes L , Boda J , Szilvassy Z , Kovacs P
Ref : Diabetes Metab , 29 :613 , 2003
Abstract : Paragh_2003_Diabetes.Metab_29_613
ESTHER : Paragh_2003_Diabetes.Metab_29_613
PubMedSearch : Paragh_2003_Diabetes.Metab_29_613
PubMedID: 14707891

Title : High-speed detection of the two common paraoxonase polymorphisms Leu55-->Met and Gln192-->Arg by real-time fluorescence PCR and melting curves - Harangi_2002_Clin.Chem.Lab.Med_40_337
Author(s) : Harangi M , Aslanidis C , Paragh G , Schmitz G
Ref : Clinical Chemistry & Laboratory Medicine , 40 :337 , 2002
Abstract : Harangi_2002_Clin.Chem.Lab.Med_40_337
ESTHER : Harangi_2002_Clin.Chem.Lab.Med_40_337
PubMedSearch : Harangi_2002_Clin.Chem.Lab.Med_40_337
PubMedID: 12059071

Title : Determination of DNA damage induced by oxidative stress in hyperlipidemic patients - Harangi_2002_Mutat.Res_513_17
Author(s) : Harangi M , Remenyik EE , Seres I , Varga Z , Katona E , Paragh G
Ref : Mutat Res , 513 :17 , 2002
Abstract : Harangi_2002_Mutat.Res_513_17
ESTHER : Harangi_2002_Mutat.Res_513_17
PubMedSearch : Harangi_2002_Mutat.Res_513_17
PubMedID: 11719086

Title : [Changes in lipid profile and paraoxonase activity in obese patients as a result of orlistat treatment] - Audikovszky_2001_Orv.Hetil_142_2779
Author(s) : Audikovszky M , Pados G , Seres I , Harangi M , Fulop P , Katona E , Winkler G , Paragh G
Ref : Orvosi Hetilap , 142 :2779 , 2001
Abstract : Audikovszky_2001_Orv.Hetil_142_2779
ESTHER : Audikovszky_2001_Orv.Hetil_142_2779
PubMedSearch : Audikovszky_2001_Orv.Hetil_142_2779
PubMedID: 11820148

Title : Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates? - Balogh_2001_Diabetes.Metab_27_604
Author(s) : Balogh Z , Seres I , Harangi M , Kovacs P , Kakuk G , Paragh G
Ref : Diabetes Metab , 27 :604 , 2001
Abstract : Balogh_2001_Diabetes.Metab_27_604
ESTHER : Balogh_2001_Diabetes.Metab_27_604
PubMedSearch : Balogh_2001_Diabetes.Metab_27_604
PubMedID: 11694861

Title : [The role of HDL in the prevention of cardiovascular events] - Paragh_2001_Orv.Hetil_142_121
Author(s) : Paragh G , Harangi M
Ref : Orvosi Hetilap , 142 :121 , 2001
Abstract : Paragh_2001_Orv.Hetil_142_121
ESTHER : Paragh_2001_Orv.Hetil_142_121
PubMedSearch : Paragh_2001_Orv.Hetil_142_121
PubMedID: 11217160

Title : Serum paraoxonase activity changes in uremic and kidney-transplanted patients - Paragh_1999_Nephron_83_126
Author(s) : Paragh G , Asztalos L , Seres I , Balogh Z , Locsey L , Karpati I , Matyus J , Katona E , Harangi M , Kakuk G
Ref : Nephron , 83 :126 , 1999
Abstract : Paragh_1999_Nephron_83_126
ESTHER : Paragh_1999_Nephron_83_126
PubMedSearch : Paragh_1999_Nephron_83_126
PubMedID: 10516491